3.Congenital Fibrous Epulis in the Infant.
Mustafa INAN ; Omer YALCIN ; Mehmet PUL
Yonsei Medical Journal 2002;43(5):675-677
Congenital fibrous epulis is an extremely rare tumor of infancy. It is a benign gingival tumor and generally seen in maxillary alveolar crest and its etiology remains the subject of debate. Congenital fibrous epulis could be considered a hamartomatous lesion. Histologically it does not show the closely packed large granular cells necessary for the diagnosis of an ordinary congenital epulis. Instead, it consists of irregular bundles of collagenous connective tissue, varying numbers of fusiform cells with oval or fusiform shaped nuclei and mild subepithelial inflammatory infiltration with tiny blood vessels and in this case a woven bone spicule in the deep area. Recommended treatment for this tumor is simple excision. We report upon a case of congenital fibrous epulis in a male infant and discuss the clinical features, histopathologic findings, and surgical treatment.
Case Report
;
Gingival Diseases/*congenital/pathology/*surgery
;
Human
;
Infant
;
Male
4.Prognostic Significance of Retroperitoneal Lymphadenectomy, Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Primary Fallopian Tube Carcinoma: A Multicenter Study.
Kemal GUNGORDUK ; Ibrahim E ERTAS ; Aykut OZDEMIR ; Emrah AKKAYA ; Elcin TELLI ; Salih TASKIN ; Mehmet GOKCU ; Ahmet Baris GUZEL ; Tufan OGE ; Levent AKMAN ; Tayfun TOPTAS ; Ulas SOLMAZ ; Askin DOGAN ; Mustafa Cosan TEREK ; Muzaffer SANCI ; Aydin OZSARAN ; Tayyup SIMSEK ; Mehmet Ali VARDAR ; Omer Tarik YALCIN ; Sinan OZALP ; Yusuf YILDIRIM ; Firat ORTAC
Cancer Research and Treatment 2015;47(3):480-488
PURPOSE: The purpose of this study is to evaluate the prognostic role of preoperative neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) and the need for para-aortic lymphadectomy in patients with primary fallopian tube carcinoma (PFTC). MATERIALS AND METHODS: Ninety-one patients with a diagnosis of PFTC were identified through the gynecologic oncology service database of six academic centers. Clinicopathological, surgical, and complete blood count data were collected. RESULTS: In univariate analysis, advanced stage, suboptimal surgery, and NLR > 2.7 were significant prognostic factors for progression-free survival, whereas in multivariate analysis, only advanced stage and suboptimal surgery were significant. In addition, in univariate analysis, cancer antigen 125 > or = 35 U/mL, ascites, advanced stage, suboptimal surgery, NLR > 2.7, PLR > 233.3, platelet count > or =400,000 cells/mm3, staging type, and histological subtype were significant prognostic factors for overall survival (OS); however, in multivariate analysis, only advanced stage, suboptimal surgery, NLR > 2.7, and staging type were significant. Inclusion of pelvic and para-aortic lymphadenectomy in surgery showed significant association with longer OS, with a mean and median OS of 42.0 months and 35.5 months (range, 22 to 78 months), respectively, vs. 33.5 months and 27.5 months (range, 14 to 76 months), respectively, for patients who underwent surgery without para-aortic lymphadenectomy (hazard ratio, 3.1; 95% confidence interval, 1.4 to 5.7; p=0.002). CONCLUSION: NLR (in both univariate and multivariate analysis) and PLR (only in univariate analysis) were prognostic factors in PFTC. NLR and PLR are inexpensive and easy tests to perform. In addition, patients with PFTC who underwent bilateral pelvic and para-aortic lymphadenectomy had longer OS.
Ascites
;
Blood Cell Count
;
Blood Platelets*
;
Diagnosis
;
Disease-Free Survival
;
Fallopian Tubes*
;
Female
;
Humans
;
Lymph Node Excision*
;
Lymphocytes*
;
Multivariate Analysis
;
Neutrophils*
;
Platelet Count
5.Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.
Nazli TOPFEDAISI OZKAN ; Mehmet Mutlu MEYDANLI ; Mustafa Erkan SARI ; Fuat DEMIRKIRAN ; Ilker KAHRAMANOGLU ; Tugan BESE ; Macit ARVAS ; Hanifi ŞAHIN ; Ali HABERAL ; Husnu CELIK ; Gonca COBAN ; Tufan OGE ; Omer Tarik YALCIN ; Özgür AKBAYIR ; Baki ERDEM ; Ceyhun NUMANOĞLU ; Nejat ÖZGÜL ; Gökhan BOYRAZ ; Mehmet Coşkun SALMAN ; Kunter YÜCE ; Murat DEDE ; Mufit Cemal YENEN ; Salih TAŞKIN ; Duygu ALTIN ; Uğur Fırat ORTAÇ ; Hülya AYDIN AYIK ; Tayup ŞIMŞEK ; Tayfun GÜNGÖR ; Kemal GÜNGÖRDÜK ; Muzaffer SANCI ; Ali AYHAN
Journal of Gynecologic Oncology 2017;28(5):e65-
OBJECTIVE: To determine factors influencing overall survival following recurrence (OSFR) in women with low-risk endometrial cancer (EC) treated with surgery alone. METHODS: A multicenter, retrospective department database review was performed to identify patients with recurrent “low-risk EC” (patients having less than 50% myometrial invasion [MMI] with grade 1 or 2 endometrioid EC) at 10 gynecologic oncology centers in Turkey. Demographic, clinicopathological, and survival data were collected. RESULTS: We identified 67 patients who developed recurrence of their EC after initially being diagnosed and treated for low-risk EC. For the entire study cohort, the median time to recurrence (TTR) was 23 months (95% confidence interval [CI]=11.5–34.5; standard error [SE]=5.8) and the median OSFR was 59 months (95% CI=12.7–105.2; SE=23.5). We observed 32 (47.8%) isolated vaginal recurrences, 6 (9%) nodal failures, 19 (28.4%) peritoneal failures, and 10 (14.9%) hematogenous disseminations. Overall, 45 relapses (67.2%) were loco-regional whereas 22 (32.8%) were extrapelvic. According to the Gynecologic Oncology Group (GOG) Trial-99, 7 (10.4%) out of 67 women with recurrent low-risk EC were qualified as high-intermediate risk (HIR). The 5-year OSFR rate was significantly higher for patients with TTR ≥36 months compared to those with TTR <36 months (74.3% compared to 33%, p=0.001). On multivariate analysis for OSFR, TTR <36 months (hazard ratio [HR]=8.46; 95% CI=1.65–43.36; p=0.010) and presence of HIR criteria (HR=4.62; 95% CI=1.69–12.58; p=0.003) were significant predictors. CONCLUSION: Low-risk EC patients recurring earlier than 36 months and those carrying HIR criteria seem more likely to succumb to their tumors after recurrence.
Cohort Studies
;
Endometrial Neoplasms*
;
Female
;
Humans
;
Multivariate Analysis
;
Neoplasm Recurrence, Local
;
Recurrence*
;
Retrospective Studies
;
Survival Analysis
;
Turkey